Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up
| Autor: | E. L. Paattiniemi, H. Naboulsi, Peter Lüthje, S. Pigg, H. Sarkkinen, Matti Kataja, J. P. Kaukonen, Ilona Nurmi-Lüthje, R. Tiihonen |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Survival Endocrinology Diabetes and Metabolism Hip fracture Cohort Studies Internal medicine medicine Humans Serum 25-hydroxyvitamin D Mortality Serum 25 hydroxyvitamin d Vitamin D Prospective cohort study Finland Aged Aged 80 and over Relative survival business.industry Hip Fractures Bayes Theorem Prospective cohort medicine.disease Vitamin D Deficiency Rheumatology Cohort Orthopedic surgery Original Article Female business Cohort study Follow-Up Studies |
| Zdroj: | Osteoporosis International |
| ISSN: | 1433-2965 |
| Popis: | Summary The association between serum 25-hydroxyvitamin D level and post-fracture mortality indicates beneficial relatively high serum 25-hydroxyvitamin D concentrations. A 1-year cohort study on 245 hip fracture patients in Finland indicated the lowest 3-year mortality and highest survival among patients with serum 25-hydroxyvitamin D level of 50–74 nmol/L. Purpose To explore pre-fracture serum 25-hydroxyvitamin D level as a factor associated with post-fracture survival among a cohort of hip fracture patients in Finland. Methods A prospectively collected cohort of hip fracture patients (n = 245, 70% women) from two hospitals was followed for 3.2 post-hip fracture years. Serum 25-hydroxyvitamin D was measured in admission to the hospital and classified |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink